Back to search
Solid Tumour Refractory to Conventional Treatment
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Solid Tumour Refractory to Conventional Treatment trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Solid Tumour Refractory to Conventional Treatment trials you may qualify forThis is a single-arm, open-label, dose-escalation and dose-expansion Phase I clinical trial evaluating the safety, tolerability, pharmacokinetics, and prelimina…
This study will investigate the use of a new drug targeting the DNA repair pathway AZD6738, an ATR inhibitor). Many tumours have lost important DNA repair funct…
The goal of this clinical trial is to test SNK02 in participants with pathologically confirmed cancer that is refractory to conventional therapy. The main quest…